Interaction of S-sulfonated human IgG with human complement and its components.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Journal of Biochemistry (Tokyo)

• Publication date

  1977-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/OXFORDJOURNALS.JBCHEM.A131799PMID 336617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin.

  1977cited by this paper
• Development of an intravenous gamma-globulin with Fc activities. I. Preparation and characterization of S-sulfonated human gamma-globulin.

  1977cited by this paper
• Investigations of the complement-fixing sites of immunoglobulins.

  1976cited by this paper
• Reconstruction of intact gamma-globulin from S-sulfonated gamma-globulin in vivo.

  1976cited by this paper
• Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4.

  1976cited by this paper
• Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions.

  1976cited by this paper
• The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.

  1975cited by this paper
• A new method for the preparation of EAC14 cell with human or guinea-pig serum.

  1974cited by this paper
• Studies on the complement-binding site of rabbit immunoglobulin G-11. The reaction of rabbit IgG and its fragments with Clq.

  1974cited by this paper
• THE REACTION MECHANISM OF HUMAN C5 IN IMMUNE HEMOLYSIS

  1970cited by this paper
• The separation of nine components and two inactivators of components of complement in humansserum.

  1970cited by this paper
• [Elimination of complement fixation of gamma-globulin by chemical modification with beta-propiolactone].

  1969cited by this paper
• The covalent structure of a human gamma G-immunoglobulin. IV. The interchain disulfide bonds.

  1968cited by this paper
• The effect of carbamylation and amidination of rabbit gamma-G-antibody on its ability to fix complement.

  1968cited by this paper
• Contribution of tryptophan to the biologic properties of anti-dinitrophenyl antibody.

  1967cited by this paper
• ENHANCEMENT OF THE HEMOLYTIC ACTIVITY OF THE SECOND COMPONENT OF HUMAN COMPLEMENT BY OXIDATION

  1967cited by this paper
• Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

  1966cited by this paper
• Effect of Mercaptoethanol on Complement Binding Ability of Human 7 S Gammaglobulin.∗

  1963cited by this paper
• CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.

  1963cited by this paper
• Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier.

  1962cited by this paper
• Biologic activity of aggregated gamma-globulin. II. A study of various methods for aggregation and species differences.

  1960cited by this paper

• Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.

  2015cites this paper
• [Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations].

  1983cites this paper
• Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A.

  1982cites this paper
• Verträglichkeit eines neuen, intravenös applizierbaren Immunglobulin-präparats und sein Effekt auf die Serumglobulinkonzentration

  1982cites this paper
• [Tolerance of a new intravenously applied immunoglobulin preparation and its effect on serum globulin levels].

  1982cites this paper
• Opsonic activity of agammaglobulinemia serum determined by oxygen consumption capacity of leukocytes.

  1981cites this paper
• [Therapeutic use of immunoglobulins in children (author's transl)].

  1980cites this paper
• Therapeutische Anwendung von Immunglobulinen bei Kindern

  1980cites this paper